Spectrofluorometric determination of linagliptin in bulk and in pharmaceutical dosage form
Open Access
- 30 June 2014
- journal article
- Published by European Journal of Chemistry in European Journal of Chemistry
- Vol. 5 (2), 380-382
- https://doi.org/10.5155/eurjchem.5.2.380-382.845
Abstract
Simple and precise spectrofluorometric method has been developed and validated for the determination of linagliptin (LNG) in the range of 10-110 μg/mL. The results obtained were of good precision and statistically compared to the reference method using one-way analysis of variance (ANOVA). The method developed was satisfactorily applied to the analysis of the pharmaceutical formulation and proved to be specific and accurate for the quality control of linagliptin in its pharmaceutical dosage form. The development of spectrofluorometric method for the determination of LNG was of interest as no such methods have been reported.Keywords
This publication has 5 references indexed in Scilit:
- Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibitionClinical Science, 2009
- Application of first-derivative, ratio derivative spectrophotometry, TLC-densitometry and spectrofluorimetry for the simultaneous determination of telmisartan and hydrochlorothiazide in pharmaceutical dosage forms and plasmaIl Farmaco, 2005
- Spectrofluorimetric analysis of certain 4-quinolone in pharmaceuticals and biological fluidsPharmaceutica Acta Helvetiae, 2000
- Fluorimetric determination of some thioxanthene derivatives in dosage forms and biological fluidsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Spectroflourimetric determination of some pharmaceutically important thioxanthene derivativesAnalytica Chimica Acta, 1991